DSL(SH:603233) Zhong Guo Zhi Liang Xin Wen Wang·2025-09-11 08:21Core Viewpoint - The "National Drug Safety Publicity Week" in China, held from September 1 to September 7, 2025, focuses on the theme "Drug Safety, Regulation for the People," with various activities organized by market supervision departments in Zhanjiang City to enhance public awareness and understanding of drug safety and regulations [1][2][3]. Group 1: Activities and Engagement - Various forms of public engagement were utilized, including science popularization, public open days, and free health services such as blood pressure testing and herbal tea distribution [2][4]. - The activities featured interactive elements like Q&A sessions, distribution of educational materials, and demonstrations of common drug safety practices [5][6]. - A total of 250 promotional materials related to drugs, medical devices, and cosmetics were distributed, along with over 900 educational handouts on safe medication practices [2][3]. Group 2: Educational Focus - The events emphasized the importance of understanding drug safety laws, including the "Drug Safety Law of the People's Republic of China" and regulations on medical devices and cosmetics [2][3]. - Educational materials included handbooks on safe medication, adverse drug reactions, and how to identify false drug advertisements, aimed at increasing public awareness and knowledge [5][6]. - Specific attention was given to children's medication safety and the dangers of drug abuse, with tailored materials and guidance provided to families [6][7]. Group 3: Community Involvement - The activities encouraged community participation, with local pharmacies and health professionals actively involved in providing consultations and health services [4][6]. - The market supervision departments collaborated with local businesses to enhance the reach of the drug safety message, utilizing electronic displays and community events to promote awareness [7][8]. - Overall, the initiative aimed to foster a supportive environment for drug safety, encouraging public engagement and legal awareness among both consumers and drug producers [4][8].